Cabozantinib-related pneumothorax in responsive patients with renal cell carcinoma: a case report
Abstract Background Cabozantinib is a multi-kinase inhibitor that has been shown to be effective in the treatment of unresectable or metastatic renal cell carcinoma and unresectable hepatocellular carcinoma that worsened after anticancer drug therapy. Tyrosine kinase inhibitors (TKIs) are known to s...
Збережено в:
| Автори: | , , |
|---|---|
| Формат: | Artigo |
| Мова: | Inglês |
| Опубліковано: |
BMC
2026-07-01
|
| Серія: | Journal of Medical Case Reports |
| Предмети: | |
| Онлайн доступ: | https://doi.org/10.1186/s13256-026-06030-x |
| Теги: |
Немає тегів, Будьте першим, хто поставить тег для цього запису!
|